Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
CA 2641217 A1 · Owner: Horton, Holly · Inventors: Felgner, Philip; Parker, Suezanne; Manthorpe, Marston
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a pharmaceutical composition comprising , a non-infectious, non-integrating polynucleotide construct comprising a polynucleotide encoding an interferon .omega. and one or more cationic compounds. , The present invention also provides methods of treating cancer in a mammal comprising administering into a tissue of the mammal a non-infectious non-integrating polynucleotide construct comprising a polynucleotide encoding a , cytokine. In addition, the present invention also relates to the methodology for , selective transfection of malignant cells with polynucleotides expressing therapeutic or prophylactic molecules in intracavity tumor bearing mammals. More …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 20, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 20, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 20, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.